These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 14761703)

  • 1. Hallucinogens.
    Nichols DE
    Pharmacol Ther; 2004 Feb; 101(2):131-81. PubMed ID: 14761703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics.
    Nichols DE
    Pharmacol Rev; 2016 Apr; 68(2):264-355. PubMed ID: 26841800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hallucinogens, serotonin and obsessive-compulsive disorder.
    Delgado PL; Moreno FA
    J Psychoactive Drugs; 1998; 30(4):359-66. PubMed ID: 9924841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of serotonin 5-HT2A receptor-mediated cGMP formation: the essential role of glutamate.
    Regina MJ; Bucelli RC; Winter JC; Rabin RA
    Brain Res; 2004 Apr; 1003(1-2):168-75. PubMed ID: 15019576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex.
    Underwood MD; Mann JJ; Huang YY; Arango V
    Alcohol Clin Exp Res; 2008 Apr; 32(4):593-9. PubMed ID: 18241316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hallucinogens and Serotonin 5-HT
    López-Giménez JF; González-Maeso J
    Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.
    Muschamp JW; Regina MJ; Hull EM; Winter JC; Rabin RA
    Brain Res; 2004 Oct; 1023(1):134-40. PubMed ID: 15364028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
    González-Maeso J; Weisstaub NV; Zhou M; Chan P; Ivic L; Ang R; Lira A; Bradley-Moore M; Ge Y; Zhou Q; Sealfon SC; Gingrich JA
    Neuron; 2007 Feb; 53(3):439-52. PubMed ID: 17270739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.
    Marona-Lewicka D; Nichols DE
    Pharmacol Biochem Behav; 2007 Oct; 87(4):453-61. PubMed ID: 17618679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelics as Medicines: An Emerging New Paradigm.
    Nichols DE; Johnson MW; Nichols CD
    Clin Pharmacol Ther; 2017 Feb; 101(2):209-219. PubMed ID: 28019026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Applications of Classic Hallucinogens.
    Bogenschutz MP; Ross S
    Curr Top Behav Neurosci; 2018; 36():361-391. PubMed ID: 28512684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelics and schizophrenia.
    González-Maeso J; Sealfon SC
    Trends Neurosci; 2009 Apr; 32(4):225-32. PubMed ID: 19269047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin research: contributions to understanding psychoses.
    Geyer MA; Vollenweider FX
    Trends Pharmacol Sci; 2008 Sep; 29(9):445-53. PubMed ID: 19086254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
    Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
    Elife; 2018 Oct; 7():. PubMed ID: 30355445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception.
    Wallach JV
    Med Hypotheses; 2009 Jan; 72(1):91-4. PubMed ID: 18805646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
    Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
    Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.